Polymorphisms within the protein tyrosine phosphatase IB (PTPN1) gene promoter: Functional characterization and association with type 2 diabetes and related metabolic traits

Clinical Chemistry

Volumn 53, Issue 9, 2007, Pages 1585-1592

  Meshkani, Reza ^a,b   Taghikhani, Mohammad ^c   Al Kateb, Hussam ^b   Larijani, Bagher ^d   Khatami, Shohreh ^e   Sidiropoulos, G Konstantinos ^b   Hegele, Robert Alexander ^f   Adeli, Khosrow ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

^f ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; PROTEIN TYROSINE PHOSPHATASE 1B;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HEREDITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BINDING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BINDING SITES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENOTYPE; GLUCOSE INTOLERANCE; HUMANS; LUCIFERASES; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE-PHOSPHATASE; TRANSCRIPTION FACTORS;

EID: 34548361384     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.088146     Document Type: Article

References (34)

1. Hamman R. Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992;8:287-338.
2. Iselius L, Lindssten J, Morton NE, Efendic S, Serasi E, Haegermark A, et al. Genetic regulation of the kinetics of glucose-induced insulin release in man: studies in families with diabetic and non-diabetic probands. Clin Genet 1985;28:8-15.
3. Bugardus C, Lillioja S, Nyomba BL, Zurlo F, Awinburn B, Esposito-Del Puente A, et al. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989; 38:1423-32.
4. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002;90:3G-10G.
5. Olefsky JM, Garwey WT, Henry RR, Brillon D, Matthhaei S, Freidenberg GR. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 1988;85:86-105.
6. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B: possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 2000;275:4283-9.
7. Kenner KA, Anyanwu E, Olefsky, JM, Kusari J. Protein tyrosine phosphatase 1B is a negative regulator of insulin and insulin-like growth factor-I-stimulated signaling. J Biol Chem 1996;27: 19810-6.
8. Kennedy BP, Ramachandran C. Protein tyrosine phosphatase-1B in diabetes. Biochem Pharmacol 2000;60:877-83.
9. Mok A, Cao H, Zinman B, Hanley AJ, Harris SB, Kennedy BP, et al. Single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance. J Clin Endocrinol Metab 2002;87:724-7.
10. Echwald SM, Bach H, Vestergaard H, Richelsen B, Kristensen K, Drivsholm T, et al. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 2002;51:1-6.
11. Di Paola R, Miscio G, Bozzali M, Bozzali M, Barrata R, Centra M, et al. Variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 2002;70:806-12.
12. Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 2004;53:3007-12.
13. Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, et al. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 2004;53:3013-9.
14. Olivier M, Hsiung CA, Chuang LM, Ho LT, Ting CT, Bustus VI, et al. Single nucleotide polymorphisms in protein tyrosine phosphatase 1B (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet 2004;13:1885-92.
15. Florez JC, Agapakis CM, Burtt NP, Sun M, Almgren P, Rastam L, et al. Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes 2005;54:1884-91.
16. McGuire MC, Fields RM, Nyomba BL, Raz I, Bogardus C, Tonks NK, et al. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes 1991;40:939-42.
17. Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistance human obesity and diabetes. J Clin Invest 1998;100:449-58.
18. The International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20: 1183-97.
20. Meshkani R, Taghikhani M, Larijani B, Khatami S, Khoshbin E, Adeli K. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 2006;371:169-75.
21. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
22. Murabito JM, Nam BH, D'Agostino RB, Lloyd-Jones DM, O'Donnell CJ, Wilson PW. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004;140:434-40.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
24. Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci [Abstract]. Am J Hum Genet 1993;53:460-5.
25. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50.
26. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999;283:1544-8.
27. Weng J, Yan J, Huang Z, Sui Y, Xiu L. Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B (PTP-1B) is not associated with type 2 diabetes in a Chinese Han population. Diabetes Care 2003;26:2957.
28. Kipfer-Coudreau S, Eberle D, Sahbatou M, Bonhomme A, Guy-Grand B, Froguel P, et al. Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 2004;47:1278-84.
29. Santaniemi M, Ukkola O, Kesaniemi YA. Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes. J Intern Med 2004;256:48-55.
30. Dahlman I, Wahrenberg H, Persson L, Arner P. No association of reported functional protein tyrosine phosphatase 1B 3′ UTR gene polymorphism with features of the metabolic syndrome in Swedish people. J Intern Med 2004;255:694-5.
31. Spencer-Jones NJ, Wang X, Snieder H, Spector TD, Carter ND, O'Dell SD. Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 2005;54:3296-304.
32. Kotowski IK, Pertsemlidis A, Luke A, Cooper RS, Vega GL, Cohen JC, et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 2006;78:410-22.
33. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-20.
34. Ukkola O, Rankinen T, Lakka T, Leon AS, Skinner JS, Wilmore JH, et al. Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. Obes Res 2005;13:829-34.